MNKD (MANNKIND CORPORAT)
All Pro Portfolios with MNKD
- Total Pro Portfolios with MNKD:
- Bill Miller
- Narragansett Management
- show more
All Do-It-Yourself Portfolios with MNKD
- Total Do-It-Yourself Portfolios with MNKD:
- JAY
- TBill87 Portfolio 1
- EdwinF Portfolio 1
- EdC1979 Portfolio 1
- finalfour Portfolio 1
- tauber Portfolio 1
- LASER3
- oatdavern Portfolio 1
- Russell's picks
- toby25 Portfolio 1
- Big Gainers
- volatily implied
- gmcopeland Portfolio 1
- rickyy7 Portfolio 1
- TRADING_ST
- revans8787 Portfolio 1
- rlsess
- GWR
- Shortsqueeze/slaughter
- scott715
- loriegirl39 Portfolio 1
- JK
- alexandrepsf Portfolio 1
- Cacique Small Growth
- lpearson Portfolio 1
- morrisseysixman Portfolio 1
- rjallen1 Portfolio 1
- no more shifts
- Insider Biotech Buys
- joe9897654 Portfolio 1
- 349795 Portfolio 1
- avamvakias Portfolio 1
- Rocket Stocks For The Week of April 14-April 18
- Rafic Portfolio 1
- show more
- 68
- mcmoney
- rodric Portfolio 1
- Jigsy Portfolio 1
- stockerblog.com Atmospheric Price Sales Ratios
- jmcgary Portfolio 1
- R/D bio/pharm
- bonez
- patelbhavik69 Portfolio 1
- crenny53 Portfolio 1
- unknownformula Portfolio 1
- rmk2Biotech
- SUPRATRADE 0906071419 FAILING DOWN
- MLB999 Portfolio 1
- yaweh Portfolio 1
- jhjones0 Portfolio 1
- mrmac702 Portfolio 1
- gwreed Portfolio 1
- JABAR123GWR
- scjs4r speculative
- Cacique Investments
- sapa15 Portfolio 1
- avrash Portfolio 1
- bisheb Portfolio 1
- acs1234 Portfolio 1
- SUPRATRADE TODAY´S PORTFOLIO-0609070842
- Estromholt stocks
- weiminzhu Portfolio 1
- Funny Money 2
- isellis Portfolio 1
- mtrudeau Portfolio 1
- pjs stocks2
- PART 4 JPMorgan 26th Annual Healthcare Conf 1/8/08..2nd Day Reporting Companies..Nymph Take
- Rocket Stocks For The Week of April 14-April 18
- first portfolio for vittorio
- News For Selected Stock
- Related stories on theStreet.com
- videos related to etf's
- No videos found
- blogs related to etf's
- No blogs found
Why I Love This Stock |
|
By:pratomorone |
Date:09 24 08 |
I have faith in Al Mann |
|
Not yet rated
Rate now:
|
|
By:Pro |
Date:11 30 -1 |
Mannkind (MNKD) was downgraded from Overweight to Neutral, JP Morgan said. New analyst believes that Pfizer's pulling of Exubera from the market has cast a pall across the entire inhalable insulin market. |
|
Not yet rated
Rate now:
|
|
By:mdmgso |
Date:10 17 07 |
Spec drug play |
|
Not yet rated
Rate now:
|
|
By:M.J.B. |
Date:10 16 07 |
Diabetes in family. Company investigating insulin that can be inhaled. |
|
Not yet rated
Rate now:
|
|
By:penman22 |
Date:10 11 07 |
hunch |
|
Not yet rated
Rate now:
|
|
By:Pro |
Date:11 30 -1 |
Mannkind (MNKD) was downgraded from Buy to Neutral at Oppenheimer. Partnership delays will affect Technosphere, and the company lacks potential catalysts by the end of the year. |
|
Not yet rated
Rate now:
|
|
By:mgeeezy1 |
Date:06 21 07 |
20% short. These guys have inhalable insulin carrier in Phase 3 studies. Implied volitilty is way up their. Huge amount of call buying in early june. I made a lot on the calls in early june but expect a huge move in the stock if they announce good results or an update on the study. |
|
Not yet rated
Rate now:
|
|
By:gwreed |
Date:06 21 07 |
EXPECTING GOOD RESULTS ON CANCER TEST |
|
Not yet rated
Rate now:
|
|
By:gwreed |
Date:06 21 07 |
EXPECTING GOOD RESULTS ON CANCER TEST |
|
Not yet rated
Rate now:
|
|
By:degenerate |
Date:06 21 07 |
interesting kiplinger's article |
|
Not yet rated
Rate now:
|
|
Why I Hate This Stock |
|
| Comments not available |